SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0482
0.00 (0.00%)
Apr 19, 2024, 4:00 PM EDT - Market closed

SQZB Statistics

Total Valuation

SQZB has a market cap or net worth of $825,750. The enterprise value is -$16.85 million.

Market Cap 825,750
Enterprise Value -16.85M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 3.08%
Owned by Institutions (%) 62.22%
Float 21.49M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.04
Forward PS n/a
PB Ratio 0.02
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.61.

Current Ratio 3.50
Quick Ratio n/a
Debt / Equity 0.61
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -119.80% and return on invested capital (ROIC) is -120.46%.

Return on Equity (ROE) -119.80%
Return on Assets (ROA) -59.90%
Return on Capital (ROIC) -120.46%
Revenue Per Employee $351,132
Profits Per Employee -$1.44M
Employee Count 53
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.81% in the last 52 weeks. The beta is 1.67, so SQZB's price volatility has been higher than the market average.

Beta (1Y) 1.67
52-Week Price Change -92.81%
50-Day Moving Average 0.05
200-Day Moving Average 0.06
Relative Strength Index (RSI) 53.11
Average Volume (30 Days) n/a

Short Selling Information

Short Interest 811,150
Short Previous Month 743,030
Short % of Shares Out n/a
Short % of Float 3.78%
Short Ratio (days to cover) 27.26

Income Statement

In the last 12 months, SQZB had revenue of $18.61 million and -$76.11 million in losses. Loss per share was -$2.61.

Revenue 18.61M
Gross Profit 18.61M
Operating Income -77.89M
Pretax Income -76.11M
Net Income -76.11M
EBITDA -64.13M
EBIT -76.11M
Loss Per Share -$2.61
Full Income Statement

Balance Sheet

The company has $42.18 million in cash and $24.50 million in debt, giving a net cash position of $17.68 million.

Cash & Cash Equivalents 42.18M
Total Debt 24.50M
Net Cash 17.68M
Net Cash Per Share n/a
Equity / Book Value 40.16M
Book Value Per Share n/a
Working Capital 31.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.89 million and capital expenditures -$359,000, giving a free cash flow of -$87.25 million.

Operating Cash Flow -86.89M
Capital Expenditures -359,000
Free Cash Flow -87.25M
FCF Per Share -$2.96
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -418.51% and -408.99%.

Gross Margin 100.00%
Operating Margin -418.51%
Pretax Margin -408.99%
Profit Margin -408.99%
EBITDA Margin -344.59%
EBIT Margin -408.99%
FCF Margin -468.81%

Dividends & Yields

SQZB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.78%
Shareholder Yield -4.78%
Earnings Yield -9,217.44%
FCF Yield -10,565.67%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) 87.25%
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on July 7, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Jul 7, 2023
Split Type Reverse
Split Ratio 1:10

Scores

SQZB has an Altman Z-Score of -8.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.24
Piotroski F-Score 2